Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FPR2 | P25090 | 2/20 | 0.32 |
| ▸ | PROKR1 | Q8TCW9 | 2/20 | 0.32 |
| ▸ | MELK | Q14680 | 4/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TYK2 | P29597 | 1/20 | 0.31 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.31 |
| ▸ | NMT1 | P30419 | 1/20 | 0.30 |
| ▸ | CDK1 | P06493 | 1/20 | 0.30 |
| ▸ | CDK4 | P11802 | 1/20 | 0.30 |
| ▸ | CCND1 | P24385 | 1/20 | 0.30 |
| ▸ | CDK2 | P24941 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | JAK3 | P52333 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10035232 | 0.87 | L3MBTL1 (0.32) | NMT1L3MBTL1 | |
| SCHEMBL10035241 | 0.86 | PTGER4 (0.33) | LRRK2 | |
| SCHEMBL10035236 | 0.84 | L3MBTL1 (0.31) | LRRK2L3MBTL1 | |
| SCHEMBL10035229 | 0.83 | KDM4E (0.31) | POLBL3MBTL1 | |
| SCHEMBL10035234 | 0.82 | ABCB1 (0.36) | — | |
| SCHEMBL1780784 | 0.82 | PDE4B (0.34) | MELKTYK2LRRK2CDK1CDK4 | |
| SCHEMBL14124696 | 0.81 | ALDH1A1 (0.32) | — | |
| SCHEMBL14124742 | 0.81 | ABCB1 (0.33) | — | |
| SCHEMBL2747608 | 0.80 | CDK8 (0.32) | L3MBTL1 | |
| SCHEMBL4584263 | 0.80 | NR3C1 (0.34) | L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8178695-B2 | Applying to unwanted plants or weeds; controlling broadleaf plants | BAYER CROPSCIENCE AG (DE) | 2012-05-15 | — | — | US | disclosed |
| US-20080254990-A1 | 4-(3-Aminobenzoyl)-1,3-dimethylpyrazoles and their use as herbicides | BAYER CROPSCIENCE AG (DE) | 2008-10-16 | — | — | US | disclosed |
| EP-1980555-A1 | 4-(3-aminobenzoyl)-1.3-dimethyl pyrazoles and their application as herbicides | Bayer CropScience Aktiengesellschaft (DE) | 2008-10-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080254990-A1 | 4-(3-Aminobenzoyl)-1,3-dimethylpyrazoles and their use as herbicides | DDT, TH, ABAT | FPR2 2945/4885PROKR1 4219/4885MELK 1061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.